Patent · US Active

Anti-VEGF antibodies and methods of use

US11820816B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Stefan Dengl · Munich, DE
Sebastian Fenn · Clapham, GB
Guy Georges · Habach, DE
Joerg Moelleken · Penzberg, DE
Francesca ROS · Penzberg, DE
Esther Koenigsberger · Penzberg, DE

Key dates

Filing date	Jun 26, 2020
Grant date	Nov 21, 2023
Priority date	—
Expiry date	Jan 6, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to anti-VEGF antibodies and methods of their production and their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.